0001019687-15-004261.txt : 20151120 0001019687-15-004261.hdr.sgml : 20151120 20151120114524 ACCESSION NUMBER: 0001019687-15-004261 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151102 FILED AS OF DATE: 20151120 DATE AS OF CHANGE: 20151120 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Rennova Health, Inc. CENTRAL INDEX KEY: 0000931059 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] IRS NUMBER: 680370244 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 44 MONTGOMERY STREET, SUITE 800 STREET 2: 400 S. AUSTRALIAN AVENUE, SUITE 800 CITY: WEST PALM BEACH STATE: FL ZIP: 33401 BUSINESS PHONE: 561-855-1626 MAIL ADDRESS: STREET 1: 44 MONTGOMERY STREET, SUITE 800 STREET 2: 400 S. AUSTRALIAN AVENUE, SUITE 800 CITY: WEST PALM BEACH STATE: FL ZIP: 33401 FORMER COMPANY: FORMER CONFORMED NAME: CollabRx, Inc. DATE OF NAME CHANGE: 20120926 FORMER COMPANY: FORMER CONFORMED NAME: TEGAL CORP /DE/ DATE OF NAME CHANGE: 19950918 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Frank Benjamin CENTRAL INDEX KEY: 0001578755 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35141 FILM NUMBER: 151245634 MAIL ADDRESS: STREET 1: 400 SOUTH AUSTRALIAN AVENUE STREET 2: 8TH FLOOR CITY: WEST PALM BEACH STATE: FL ZIP: 33401 3 1 frank_f3.xml OWNERSHIP DOCUMENT X0206 3 2015-11-02 0 0000931059 Rennova Health, Inc. RNVA 0001578755 Frank Benjamin 400 S. AUSTRALIAN AVENUE, SUITE 800 WEST PALM BEACH FL 33401 1 0 0 0 Options to Purchase Common Stock 6.11 2015-11-02 2017-04-19 Common Stock 40963 D Options to Purchase Common Stock 6.11 2015-11-02 2017-04-19 Common Stock 20481 D Received in connection with the merger transaction with Medytox Solutions, Inc. ("Medytox ") in exchange for the cancellation of options to acquire 100,000 shares of the common stock of Medytox at an exercise price of $2.50 per share, based upon an exchange ratio of 0.4096377408003329. Received in connection with the merger transaction with Medytox in exchange for the cancellation of options to acquire 50,000 shares of the common stock of Medytox at an exercise price of $2.50 per share, based upon an exchange ratio of 0.4096377408003329. /s/ Benjamin Frank 2015-11-19